Ciprofloxacin Otic Drops. It has activity against pseudomonads streptococci methicillin-resistant Staphylococcus aureus MRSA Staphylococcus epidermidis and most gram-negative organisms but has no activity against anaerobes. Because of the negligible systemic exposure associated with otic ciprofloxacin it is expected to be of minimal risk for maternal and fetal toxicity when administered to pregnant women.
Therefore caution should be exercised when CILOXAN is administered to nursing women. Use of any systemic antibacterial within four weeks prior to baseline. Each single use container of Ciprofloxacin Otic Solution delivers 025 mL of solution equivalent to 05 mg of ciprofloxacin.
Ofloxacin otic comes as a solution liquid to place into the ear.
Ciprofloxacin Ear Drops Description. It is unknown whether ciprofloxacin is excreted in human breast milk following topical ocular or otic administration. Use of any topical or otic medication. 2 Recommended treatment regimens are summarized in Table 2.